Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
Clostridium butyricum TO-A |
?
<i>Clostridium butyricum</i> CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells. Frontiers in immunology (Front Immunol ) Vol: 8 Issue Pages: 1345 Pub: 2017 Epub: 2017 Oct 19 Authors Jia L , Shan K , Pan LL , Feng N , Lv Z , Sun Y , Li J , Wu C , Zhang H , Chen W , Diana J , Sun J , Chen YQ , Html Article Publication |
Clostridium butyricum TO-A |
?
Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment. International journal of molecular medicine (Int J Mol Med ) Vol: 9 Issue 1 Pages: 65-70 Pub: 2002 Jan Epub: Authors Fukuda M , Kanauchi O , Araki Y , Andoh A , Mitsuyama K , Takagi K , Toyonaga A , Sata M , Fujiyama Y , Fukuoka M , Matsumoto Y , Bamba T , Publication |
Clostridium butyricum TO-A |
?
Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ open diabetes research & care (BMJ Open Diabetes Res Care ) Vol: 8 Issue 1 Pages: Pub: 2020 Jul Epub: Authors Perraudeau F , McMurdie P , Bullard J , Cheng A , Cutcliffe C , Deo A , Eid J , Gines J , Iyer M , Justice N , Loo WT , Nemchek M , Schicklberger M , Souza M , Stoneburner B , Tyagi S , Kolterman O , Html Article Publication |
Clostridium butyricum TO-A |
?
[Intestinal Care Using L?Glutamine Supplement and Probiotics Can Induce a Strong Anti?Tumor Immune Response through the Induction of Mature Tertiary Lymphoid Structures in Pancreatic Cancer Patients Receiving Preoperative Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho ) Vol: 48 Issue 4 Pages: 465-471 Pub: 2021 Apr Epub: Authors Ohta T , Makino I , Okazaki M , Miyashita T , Tajima H , Publication |
Clostridium butyricum TO-A |
?
The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (J Infect Chemother ) Vol: 26 Issue 5 Pages: 483-491 Pub: 2020 May Epub: 2020 Mar 9 Authors Yamaguchi T , Konishi H , Aoki K , Ishii Y , Chono K , Tateda K , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.